 |
市場調査レポート
摂取型センサーの世界市場：タイプ、アプリケーション（モニタリング、診断イメージング、医薬品管理）、エンドユーザー（ヘルスケア、スポーツ＆フィットネス）、地域別の成長率、動向および予測（2018年〜2023年）Global Ingestible Sensors Market - Segmented by type, Applications (Monitoring, Diagnostic Imaging, Medication Management), End User (Healthcare, Sports & Fitness), and Region - Growth, Trends, and Forecast (2018 - 2023) |
||||||
| 発行 | Mordor Intelligence LLP | 商品コード | 704862 | ||||
| 出版日 | ページ情報 | 英文 93 Pages 納期: 即日から翌営業日 |
|||||
| 価格 |
|
||||||
| 摂取型センサーの世界市場：タイプ、アプリケーション（モニタリング、診断イメージング、医薬品管理）、エンドユーザー（ヘルスケア、スポーツ＆フィットネス）、地域別の成長率、動向および予測（2018年〜2023年） Global Ingestible Sensors Market - Segmented by type, Applications (Monitoring, Diagnostic Imaging, Medication Management), End User (Healthcare, Sports & Fitness), and Region - Growth, Trends, and Forecast (2018 - 2023) | ||
| 出版日: 2018年08月18日 | ページ情報: 英文 93 Pages |
|
摂取型センサー市場は、予測期間（2018年〜2023年）に20.06％以上のCAGRで成長する見込みです。過去5年間にわたり、医療業界は、ウェアラブルおよび埋め込み型技術のような技術革新によって成長が推進されてきました。摂取型センサーは、医療分野における革新であり、急速に重要性を増しているデジタル医薬品（スマートピル）の構成要素です。医療分野のセンサーは、病状を治療する一環として、患者の生活習慣行動を理解するために主に使用されています。摂取型センサーは、ヘルスケア部門の主目的をサポートすることは別として、スマートピル技術に導入されることによって遠隔患者モニタリングの余地を作り出しています。
当レポートでは、世界の摂取型センサー市場を調査し、全体的な市場動向、タイプ・アプリケーション・エンドユーザー・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。
The Ingestible Sensors Market is expected to register a CAGR of over 20.06% during the forecast period (2018 - 2023). The healthcare industry, over the past five years, has been driven by the technology-based and -enabled innovations, like the wearable and embeddable technology. The ingestible sensors are components of digital medicines (also smart pills), an innovation in the healthcare sector and is gaining importance rapidly. Sensors in the healthcare sector are majorly used to understand the lifestyle behaviors of the patients as a part of treating their medical condition. Ingestible sensors, apart from supporting the main purpose in the healthcare sector also provides scope for remote patient monitoring by being deployed in the smart pill technology.
The technological advancements in the ingestible sensors are focused towards addressing the need for medical regime compliance among the senior citizens and also eliminate the need for repeated physical checkups. A significant share of healthcare technology companies and digital health startups are venturing into digital medicine technology developing their own ingestible sensors, anticipating the rapid adoption by the end users during the forecast period. Since these sensors are made up of digestible metals, like copper & magnesium and doesn't require external power to get activated, they are being slowly accepted by the end-users. The ingestible sensor technology is highly regulated and needs to be approved by FDA for the users to prescribe it to their patients. Proteus Digital Health Inc. is the first digital technology company that was given FDA approval for its ingestible tracking system enabled pill, Abilify MyCite, in 2017 after conducting more than 400 clinical trials. However, the cost of these ingestible sensors and concerns around technologies that store information of the patients' medication-taking-behavior are some of the challenges, which impact the growth of the market.
Governments across Asian regions, like India and China ("Healthy China 2030") are undertaking several initiatives aimed at improving healthcare infrastructure, and offer significant support for innovation. These investments are likely to contribute to the adoption of the ingestible sensors in the region. Going forward, advancements in the nanosensors and the flexible electronics are expected to shape the ingestible sensors technology during the forecast period.
Need to Address the Medical Regime Non-compliance Drives the Ingestible Sensors Market
According to Centers for Disease Control and Prevention (CDC), a leading national public health institute of the US, more than 150 million Americans would be prescribed chronic medications by 2020, among which about 50% are not continued as prescribed. The center mentioned that non-adherence causes failure of treatments, which leads to about 125 thousand deaths per year, in United States alone, thus, impacting the mortality rate in the region. This non-compliance is also evident in the senior citizens across regions with chronic diseases need continuous monitoring, and in most cases, physical checkups may become a challenge over a period of time. Considering the fact that more than 50% of hospital deaths occur in patients who are not continuously monitored, there exists a definite need, which the ingestible sensors appropriately address through smart pills. The rise in the number of death cases across regions due to non-availability of remote low-cost care management also drives the market under study.
Europe to be the Fastest Growing Market
The less invasive healthcare technology is expected to have a huge demand from Europe during the forecast period, considering the government initiatives in the region in line with the aging population and healthcare compliance. European government's e-health strategy supports the growth of the digital medicines through encouraging investments by the member regions in large-scale deployment of digitally-enabled, integrated, person-centered care. Through Health EU project the region plans to develop technological platform around patients using a whole range of leading-edge technologies, like portable sensors, implants, nanomedicine techniques, and medical imaging. These initiatives indicate the growth rate of the region in the ingestible sensor market. Geographically, North America has the largest market share in 2017 considering the high-quality healthcare systems, modern medical technology, and high disposable incomes in the region. Healthcare providers in a few areas in the North America have started prescribing ingestible sensor-based digital medicines.
Key Developments in the Ingestible Sensors Market
Feb 2018: Proteus Digital Health, Inc., the company with the first FDA approved smart pill/digital medicine, announced its pipeline of 31 digital medicines for treating infectious diseases, mental health, cardiovascular and metabolic conditions, and oncology. The company plans to collaborate with Otsuka Pharmaceutical Company and others in order to extend the digital medicine to treat other chronic devices.
Ingestible Sensors Market Major Players: PROTEUS DIGITAL HEALTH INC., ADHERE TECH, GIVEN IMAGING LTD, OTSUKA PHARMACEUTICAL, MEDTRONIC PLC (GIVEN IMAGING LTD), OLYMPUS MEDICAL TECHNOLOGY, CAPSOVISION INC., HQ, INC., INTROMEDIC CO., LTD and RF CO., LTD., among others.
Reasons to Purchase Ingestible Sensors Market Report
Current and future ingestible sensors market outlook in the developed and emerging markets
Analyzing various perspectives of the market with the help of Porter's five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth during the forecast period
Identifying the latest developments, market shares, and strategies employed by the major market players
3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs
